Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Recruiting2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT07018518Phase 1Recruiting
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
AdultHepatocellular Carcinoma
StudydirectorStart date: 2025-06-20
NCT06883149Phase 1Recruiting
PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor
AdultSolid Tumor
StudydirectorStart date: 2025-03-19

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Tumor Immunology, Changping Laboratory

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Weidong Han, Ph.D

Biotherapeutic Department, Chinese PLA General Hospital

Similar
12 trials

Shared therapeutic areas:

AdultColorectal CancerSolid Tumor+1 more

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 3 trials
Similarity Score52%

Zhijun Wang, M.D

Department of Interventional radiology, Chinese PLA General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

AdultCarcinoma, HepatocellularSolid Tumor

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 2 trials
Similarity Score38%

Guanghua Rong, Ph.D

Biotherapeutic Department, the Fifth Medical Center of the PLA General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

AdultColorectal CancerCarcinoma, Hepatocellular

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 2 trials
Similarity Score38%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerSolid Tumor
Similarity Score23%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal Cancer
Similarity Score15%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal Cancer
Similarity Score15%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerCarcinoma, Hepatocellular
Similarity Score15%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Colorectal CancerSolid Tumor
Similarity Score15%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Colorectal CancerSolid Tumor
Similarity Score15%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07018518Phase 1StudyDirector

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

AdultHepatocellular Carcinoma
Recruiting
NCT06883149Phase 1StudyDirector

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

AdultSolid Tumor
Recruiting
NCT07411781Phase 1StudyDirector

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

AdultColorectal Cancer
Not Yet Recruiting

All 3 trials loaded